Ironwood Investment Counsel LLC raised its position in CVS Health Corp (NYSE:CVS) by 11.3% during the first quarter, Holdings Channel reports. The firm owned 48,197 shares of the pharmacy operator’s stock after buying an additional 4,893 shares during the quarter. Ironwood Investment Counsel LLC’s holdings in CVS Health were worth $2,599,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Acima Private Wealth LLC purchased a new position in shares of CVS Health in the 4th quarter valued at $33,000. Bay Harbor Wealth Management LLC grew its position in shares of CVS Health by 1,871.4% in the 1st quarter. Bay Harbor Wealth Management LLC now owns 552 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 524 shares during the last quarter. Murphy Pohlad Asset Management LLC purchased a new position in shares of CVS Health in the 4th quarter valued at $39,000. C J Advisory Inc purchased a new position in shares of CVS Health in the 1st quarter valued at $33,000. Finally, 1 North Wealth Services LLC purchased a new position in shares of CVS Health in the 4th quarter valued at $42,000. 77.48% of the stock is currently owned by institutional investors.
A number of research analysts recently commented on CVS shares. Standpoint Research raised shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Wednesday, June 5th. Sanford C. Bernstein initiated coverage on shares of CVS Health in a research report on Tuesday, March 12th. They set an “outperform” rating and a $76.00 price objective on the stock. Morgan Stanley set a $92.00 price objective on shares of CVS Health and gave the stock a “buy” rating in a research report on Friday, February 22nd. ValuEngine downgraded shares of CVS Health from a “sell” rating to a “strong sell” rating in a research report on Thursday, February 28th. Finally, Credit Suisse Group downgraded shares of CVS Health from an “outperform” rating to a “neutral” rating and lowered their price objective for the stock from $73.00 to $61.00 in a research report on Monday, April 29th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company. CVS Health has a consensus rating of “Buy” and a consensus price target of $76.48.
CVS Health (NYSE:CVS) last released its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.62 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.50 by $0.12. CVS Health had a negative net margin of 0.08% and a positive return on equity of 16.80%. The company had revenue of $61.65 billion during the quarter, compared to analysts’ expectations of $60.39 billion. During the same quarter last year, the business earned $1.48 EPS. The business’s revenue was up 34.8% on a year-over-year basis. As a group, research analysts expect that CVS Health Corp will post 6.85 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “CVS Health Corp (NYSE:CVS) Holdings Raised by Ironwood Investment Counsel LLC” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The legal version of this story can be accessed at https://www.tickerreport.com/banking-finance/4370123/cvs-health-corp-nysecvs-holdings-raised-by-ironwood-investment-counsel-llc.html.
CVS Health Profile
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
Featured Article: The components of the Stochastic Momentum Index
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.